Kennesaw State University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Kennesaw State University sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Kennesaw State University: 8 sponsored US clinical trials, 4 recruiting.
Kennesaw State University sponsors 8 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Inflammation Chronic, with 1 trials.
Upper-quartile sponsor footprint
Kennesaw State University sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Mental Effort During Low Load Resistance Training in Older Adults
NCT07687316
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
NCT07221279
Influence of Fast and Slow Imagined Muscle Contractions on Muscle Function or Central Nervous System Properties
NCT06627491
Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students
NCT06259799
High Intensity Body-weight Circuit Training Feasibility and Efficacy for in Middle Aged Persons With Type 2 Diabetes
NCT05571384
Quercetin's Effect on Bone Health and Inflammatory Markers
NCT05371340
High-Intensity Interval Training and Performance
NCT05821504
High Intensity Body-weight Circuit Training in Type 2 Diabetics
NCT04515992
Therapeutic Areas
What is open in the Kennesaw State University pipeline
4 recruiting of 8 indexed (50% open); 4 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Inflammation Chronic (1 trial), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Kennesaw State University: open-pipeline peers nationwide
Peers matched on 8 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Kennesaw State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this Kennesaw State University page
8 registered trials is a research-attention snapshot, not an endorsement of Kennesaw State University or any single study.
- 4 of Kennesaw State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Inflammation Chronic is the condition Kennesaw State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Inflammation Chronic trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Kennesaw State University pipeline card: 8 registered trials from official public datasets.Report a data error.